|
End-of-day quote
Korea S.E.
14/09/2026
|
5-day change | 1st Jan Change | ||
| 7,300.00 KRW | -0.41% |
|
-3.18% | -55.21% |
| 19/05 | TegoScience Inc. agreed to acquire 95.77% stake in PNP Pharm Co., Ltd. for KRW 3.7 billion. | CI |
| 27/05/25 | TegoScience Inc. announced that it has received KRW 27 billion in funding | CI |
| Market Cap | 58.45B 43.39M 37.6M 35.48M 32.19M 60.39M 4.16B 60.82M 424M 163M 2.11B 163M 159M 6.71B | P/E 2024 |
29.9x | P/E 2025 | -18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 23.16B 17.2M 14.9M 14.06M 12.76M 23.93M 1.65B 24.1M 168M 64.71M 836M 64.59M 63.17M 2.66B | EV / Sales 2024 |
11x | EV / Sales 2025 | 16x |
| Free-Float |
51.46% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.41% | ||
| 1 week | -3.18% | ||
| Current month | -2.67% | ||
| 1 month | -14.12% | ||
| 3 months | -9.88% | ||
| 6 months | -47.82% | ||
| Current year | -55.21% |
| 1 week | 7,150 |  | 7,890 |
| 1 month | 7,000 | | 8,970 |
| Current year | 5,230 | | 16,500 |
| 1 year | 5,230 | | 19,370 |
| 3 years | 5,230 | | 26,100 |
| 5 years | 5,230 | | 28,050 |
| 10 years | 5,230 | | 73,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
CEO | Chief Executive Officer | 60 | 20/03/2001 |
Han-Kyu Jang
PRN | Corporate Officer/Principal | 53 | - |
Sung-In Chung
AUD | Comptroller/Controller/Auditor | 66 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sae-Wha Jeon
BRD | Director/Board Member | 60 | 20/03/2001 |
Jae-Wook Jeon
BRD | Director/Board Member | 63 | 20/03/2001 |
Han-Kyu Jang
BRD | Director/Board Member | 53 | 01/05/2001 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | -3.18% | -58.29% | -21.34% | 43.39M | |
| +1.57% | -4.11% | +41.74% | -4.64% | 79.26B | |
| +1.89% | +0.78% | +523.95% | +30.03% | 58.56B | |
| +1.57% | -0.31% | -14.78% | -34.90% | 58.62B | |
| +0.35% | -3.14% | -11.03% | +26.34% | 48.75B | |
| +2.38% | +0.10% | +1.49% | +155.34% | 46.32B | |
| +0.10% | -1.57% | +50.05% | -15.20% | 32.12B | |
| +0.59% | -3.60% | +47.04% | +92.49% | 24.77B | |
| -1.86% | -5.04% | -0.47% | +142.73% | 21.5B | |
| +2.24% | -0.40% | +66.12% | +100.09% | 15.97B | |
| Average | +0.66% | -1.79% | +64.58% | +47.09% | 38.59B | |
| Weighted average by Cap. | +0.93% | -1.65% | +94.52% | +37.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 6.76B 5.02M 4.35M 4.1M 3.72M 6.98M 481M 7.03M 49.01M 18.88M 244M 18.85M 18.43M 776M | 5.94B 4.41M 3.82M 3.61M 3.27M 6.14M 423M 6.18M 43.07M 16.6M 214M 16.57M 16.2M 682M |
| Net income | 3.35B 2.49M 2.15M 2.03M 1.84M 3.46M 238M 3.49M 24.29M 9.36M 121M 9.34M 9.13M 384M | -7.01B -5.21M -4.51M -4.26M -3.86M -7.24M -499M -7.3M -50.84M -19.59M -253M -19.55M -19.12M -805M |
| Net Debt | -25.58B -18.99M -16.46M -15.53M -14.09M -26.43M -1.82B -26.62M -185M -71.47M -923M -71.33M -69.76M -2.94B | -35.28B -26.2M -22.7M -21.42M -19.43M -36.45M -2.51B -36.72M -256M -98.58M -1.27B -98.39M -96.22M -4.05B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | KRW 7,300.00 | -0.41% | 1,131 |
| 11/09/26 | KRW 7,330.00 | -0.27% | 1,037 |
| 10/09/26 | KRW 7,350.00 | -2.78% | 1,386 |
| 09/09/26 | KRW 7,560.00 | +1.07% | 2,303 |
| 08/09/26 | KRW 7,480.00 | -0.80% | 1,966 |
- Stock Market
- Stocks
- A191420 Stock
Select your edition
All financial news and data tailored to specific country editions
